Antibody Drugs Market Analysis - Forecast(2021 - 2026)

Report Code: HCR 0153 Report Format: PDF + Excel (Delivery in 48 Hrs)

Antibody Drugs Market Overview

Antibody Drugs Market size is estimated to reach $139.82bn by 2025, growing at a CAGR of 6.5% during the forecast period 2020-2025. An antibody is a Y shaped protein built by the plasma cells and is used by the immune system to neutralize the harmful bacteria and viruses in the body. Antibody drugs are the medicines that are used to destroy the disease causing elements in the body. These antibody drugs are used to treat diseases like different types of infections, allergies, cancers and others. Increase funding by the government and private sectors, rising health awareness are some of the factors that are driving the growth of the market during the forecast period 2020-2025. 

Antibody Drugs Market Report Coverage

The report: “Antibody Drugs Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Antibody Drugs Market. 
By Drug Type: Monoclonal antibodies, Antibody-drug conjugates, and Polyclonal antibodies
By Application: Central nervous system, Cancers, Autoimmune disorders, Cardiovascular diseases and others
By End-Users: Hospitals, Pharmaceuticals, Clinics and Research Institutes
By Geography: North America, Asia-Pacific, Europe, and Rest of the World.

Key Takeaways

  • Geographically, North America’s Antibody Drugs Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high disposal income and availability of a large number of manufacturers for Antibody Drugs.
  • The increase in health concerns and increased prevalence of diseases like cancers, cardiovascular issues, and other infections and allergies are driving the market for Antibody Drugs during the forecast period 2020-2025.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Antibody Drugs Market report.
  • Antibody drugs are the best alternative for the diseases where the treatment is not possible, and having less side effects and development of good immunity are driving the antibody drug market.

By Drug Type - Segment Analysis

The Drug Type segment of the Antibody Drugs Market has Monoclonal antibodies, Antibody-drug conjugates, and Polyclonal antibodies. The Monoclonal antibodies segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025. These monoclonal antibodies provide a good immune system to fight the antigens like viruses, bacteria, parasites fungi and others. Antibody-drug conjugates segment is also set to have healthy growth, as they are helpful in the treatment of cancers by killing tumor cells while protecting healthy cells. Growing health issues among the people and increased health care facilities are driving the usage of antibody drugs during the forecast period 2020-2025.

By Application - Segment Analysis

The Application segment of the Antibody Drugs Market has the Central nervous system, Cancers, Autoimmune disorders and cardiovascular diseases, and others. The Autoimmune disorders segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025, owing to the increased number of people suffering from different types of autoimmune disorders, and there are over 80 types of autoimmune disorder with symptoms like low-grade fever and tiredness. The cancer segment is also set to have the fastest growth owing to the increased number of cancer patients globally. The development of new drugs for different types of diseases and increased funding by both public and private companies are driving the market during the forecast period 2020-2025.

By Geography - Segment Analysis

Based on Geography the global Antibody Drugs Market is segmented into North America, Europe, Asia-Pacific and the Rest of World. North America had a dominant share in terms of revenue in 2019 and it holds the largest market share during the forecast period 2020-2025, owing to the increased usage of Antibody Drugs. Asia-Pacific is also set to have the fastest growth owing to the increased population with different types of diseases. On the other hand, Europe is set to have healthy growth, owing to increased developments made by the manufacturers. Increased disposal income by the growing population and rising health issues like cancers, cardiovascular issues and other diseases is driving the growth of the market globally during the forecast period.

Drivers – Antibody Drugs Market

  • High prevalence of health issues

The increase in diseases like cancers, allergies, infections, and increased health care expenditure by the global population are driving the growth of the Antibody Drugs market during the forecast period 2020-2025.

Challenges – Antibody Drugs Market

High cost of drugs

The cost of the Antibody Drugs and lack of awareness among the people for using different types of diseases are challenging market. Side effects caused by the consumption of a few types of drugs are also hindering the growth of the market during the forecast period 2020-2025.

Antibody Drugs Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Antibody Drugs Market. Key companies of this market are Biogen Inc, Johnson & Johnson, Novartis AG, Amgen Inc, AbbVie Inc, Seattle Genetics Inc, Roche Holdings, Merck & Co., ImmunoGen, Inc., Pfizer Inc., and others.

Acquisitions/Product Launches:

  • In June 2020, Biogen Inc., had announced the data of sixteen weeks cutaneous lupus erythematosus portion of phase two LILAC study, This study is done to check the efficiency of the BllB059, a fully humanized IgG1 monoclonal antibody (mAb) which is used for the treatment of blood dendritic cell antigen 2, which is expressed on plasmacytoid dendritic cells.
  • In April 2016, Pfizer company get approval from FDA for its Celltrion’s INFLECTRA, this Remicade INFLECVTRA is the first and only biosimilar monoclonal antibody and second one to be approved in the U.S. INFLECTRA is used in reducing symptoms in patients who are suffering from rheumatoid arthritis, ulcreative colitis, and other diseases.

1. Antibody Drugs Market - Overview
    1.1 Definitions and Scope
2. Antibody Drugs Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Drug Type
    2.3 Key trends by Application
    2.4 Key trends by End-Users
    2.5 Key trends by Geography
3. Antibody Drugs Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies 
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Antibody Drugs Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Antibody Drugs Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Antibody Drugs - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Antibody Drugs Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Antibody Drugs Market – By Drug Type (Market Size –$Million/$Billion)
    8.1 Monoclonal antibodies
    8.2 Antibody-drug conjugates
    8.3 Polyclonal antibodies
9. Antibody Drugs Market – By Application (Market Size –$Million/$Billion)
    9.1 Central nervous system 
    9.2 Cancers
    9.3 Autoimmune disorders
    9.4 Cardiovascular diseases
    9.5 Others
10. Antibody Drugs Market – By End-Users (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Pharmaceuticals
    10.3 Clinics
    10.4 Research Institutes
11. Antibody Drugs Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Antibody Drugs Market - Entropy
13. Antibody Drugs Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Antibody Drugs Market – Key Company List by Country Premium Premium
15. Antibody Drugs Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table1: Antibody Drugs Market Overview 2019-2024
Table2: Antibody Drugs Market Leader Analysis 2018-2019 (US$)
Table3: Antibody Drugs Market Product Analysis 2018-2019 (US$)
Table4: Antibody Drugs Market End User Analysis 2018-2019 (US$)
Table5: Antibody Drugs Market Patent Analysis 2013-2018* (US$)
Table6: Antibody Drugs Market Financial Analysis 2018-2019 (US$)
Table7: Antibody Drugs Market Driver Analysis 2018-2019 (US$)
Table8: Antibody Drugs Market Challenges Analysis 2018-2019 (US$)
Table9: Antibody Drugs Market Constraint Analysis 2018-2019 (US$)
Table10: Antibody Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11: Antibody Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12: Antibody Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13: Antibody Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14: Antibody Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table15: Antibody Drugs Market Value Chain Analysis 2018-2019 (US$)
Table16: Antibody Drugs Market Pricing Analysis 2019-2024 (US$)
Table17: Antibody Drugs Market Opportunities Analysis 2019-2024 (US$)
Table18: Antibody Drugs Market Product Life Cycle Analysis 2019-2024 (US$)
Table19: Antibody Drugs Market Supplier Analysis 2018-2019 (US$)
Table20: Antibody Drugs Market Distributor Analysis 2018-2019 (US$)
Table21: Antibody Drugs Market Trend Analysis 2018-2019 (US$)
Table22: Antibody Drugs Market Size 2018 (US$)
Table23: Antibody Drugs Market Forecast Analysis 2019-2024 (US$)
Table24: Antibody Drugs Market Sales Forecast Analysis 2019-2024 (Units)
Table25: Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table26: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Central nervous system ailment, 2019-2024 ($)
Table27: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Allergic diseases, 2019-2024 ($)
Table28: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Cancer, 2019-2024 ($)
Table29: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Infections, 2019-2024 ($)
Table30: North America Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table31: South america Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table32: Europe Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table33: APAC Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table34: Middle East & Africa Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table35: Russia Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table36: Israel Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2019-2024 ($)
Table37: Top Companies 2018 (US$)Antibody Drugs Market, Revenue & Volume
Table38: Product Launch 2018-2019Antibody Drugs Market, Revenue & Volume
Table39: Mergers & Acquistions 2018-2019Antibody Drugs Market, Revenue & Volume


List of Figures

Figure 1: Overview of Antibody Drugs Market 2019-2024
Figure 2: Market Share Analysis for Antibody Drugs Market 2018 (US$)
Figure 3: Product Comparison in Antibody Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Antibody Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antibody Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antibody Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antibody Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Antibody Drugs Market 2018
Figure 9: Average Selling Price in Antibody Drugs Market 2019-2024
Figure 10: Top Opportunites in Antibody Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Antibody Drugs Market
Figure 12: GlobalBy Disease Cure Antibody Drugs Market Revenue, 2019-2024 ($)
Figure 13: Global Antibody Drugs Market - By Geography
Figure 14: Global Antibody Drugs Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Antibody Drugs Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 17: US Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 92: China Antibody Drugs Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Antibody Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Antibody Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Antibody Drugs Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Antibody Drugs Market
Figure 130: Developments, 2018-2019*Antibody Drugs Market
Figure 131: Company 1 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Antibody Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Antibody Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Antibody Drugs Market Net Sales Share, By Geography, 2018 (%)